Joseph Stringer
Stock Analyst at Needham
(2.16)
# 2,655
Out of 4,826 analysts
309
Total ratings
36.46%
Success rate
-5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joseph Stringer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintains: Buy | $60 → $55 | $33.61 | +63.64% | 21 | Apr 30, 2025 | |
| GILD Gilead Sciences | Reiterates: Hold | n/a | $102.81 | - | 5 | Apr 25, 2025 | |
| PHAT Phathom Pharmaceuticals | Reiterates: Buy | $28 | $2.59 | +983.17% | 51 | Apr 21, 2025 | |
| CDTX Cidara Therapeutics | Reiterates: Buy | $35 | $21.73 | +61.07% | 10 | Apr 10, 2025 | |
| RNA Avidity Biosciences | Reiterates: Buy | $60 | $32.28 | +85.87% | 17 | Apr 9, 2025 | |
| STOK Stoke Therapeutics | Reiterates: Buy | $22 | $9.71 | +126.57% | 22 | Apr 9, 2025 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $320 | $273.55 | +16.98% | 21 | Apr 9, 2025 | |
| PCVX Vaxcyte | Reiterates: Buy | $90 | $34.28 | +162.54% | 17 | Apr 8, 2025 | |
| INZY Inozyme Pharma | Reiterates: Buy | $15 | $1.49 | +910.10% | 18 | Apr 8, 2025 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $66 | $64.39 | +2.50% | 23 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.72 | - | 13 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.82 | +781.54% | 18 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 | $1.60 | +525.00% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $6.15 | +208.94% | 16 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $500.19 | - | 5 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $27.84 | - | 8 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $60 | $19.98 | +200.30% | 19 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $37 | $15.18 | +143.74% | 6 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $10.29 | +74.93% | 2 | Aug 24, 2021 |
Ionis Pharmaceuticals
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $55
Current: $33.61
Upside: +63.64%
Gilead Sciences
Apr 25, 2025
Reiterates: Hold
Price Target: n/a
Current: $102.81
Upside: -
Phathom Pharmaceuticals
Apr 21, 2025
Reiterates: Buy
Price Target: $28
Current: $2.59
Upside: +983.17%
Cidara Therapeutics
Apr 10, 2025
Reiterates: Buy
Price Target: $35
Current: $21.73
Upside: +61.07%
Avidity Biosciences
Apr 9, 2025
Reiterates: Buy
Price Target: $60
Current: $32.28
Upside: +85.87%
Stoke Therapeutics
Apr 9, 2025
Reiterates: Buy
Price Target: $22
Current: $9.71
Upside: +126.57%
Alnylam Pharmaceuticals
Apr 9, 2025
Reiterates: Buy
Price Target: $320
Current: $273.55
Upside: +16.98%
Vaxcyte
Apr 8, 2025
Reiterates: Buy
Price Target: $90
Current: $34.28
Upside: +162.54%
Inozyme Pharma
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $1.49
Upside: +910.10%
Rhythm Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $66
Current: $64.39
Upside: +2.50%
Mar 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.72
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $16
Current: $1.82
Upside: +781.54%
Mar 4, 2025
Downgrades: Hold
Price Target: $10
Current: $1.60
Upside: +525.00%
Feb 27, 2025
Reiterates: Buy
Price Target: $19
Current: $6.15
Upside: +208.94%
Feb 11, 2025
Reiterates: Hold
Price Target: n/a
Current: $500.19
Upside: -
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $27.84
Upside: -
Nov 6, 2024
Maintains: Buy
Price Target: $85 → $60
Current: $19.98
Upside: +200.30%
Jan 24, 2024
Upgrades: Buy
Price Target: $37
Current: $15.18
Upside: +143.74%
Aug 24, 2021
Maintains: Buy
Price Target: $32 → $18
Current: $10.29
Upside: +74.93%